Cancer Clinical Trial
Official title:
Sleep Architecture and Chemotherapy-Related Fatigue
The purpose of this study is to identify specific chemotherapy-related changes in sleep
stages/architecture that may relate to an increase in fatigue in individuals with cancer.
The researchers hypothesize that the fatigue experienced by cancer patients receiving
chemotherapy is in part due to changes in restorative sleeping during the non-rapid eye
movement cycles of sleep (i.e., delta activity).
Studies have shown a strong positive correlation between self-reported changes in sleep and
cancer patients' fatigue, and also between an objective measure of sleep continuity, [i.e.,
actigraphy and polysomnography (PSG)] and self-reported fatigue. Chemotherapy disrupts
normal sleep patterns, and fatigue, in the later stages of chemotherapy, may occur as a
result of disturbed nocturnal sleep continuity. However, the causes of chemotherapy-related
fatigue remain unknown, and whether or not abnormal sleep architecture contributes to this
debilitating effect has yet to be explored. We believe that fatigue experienced by many
cancer patients receiving chemotherapy is due, at least in part, to changes in delta
activity [i.e., restorative sleep during the non-rapid eye movement (NREM) cycles of sleep].
A finding that slow wave sleep abnormalities play a significant role in fatigue would prompt
further confirmatory studies and support controlled intervention studies.
Comparisons: In a clinical trial of individuals with cancer prior to, during, and after
completion of chemotherapy, we will identify and compare specific chemotherapy-related
changes in sleep stages/architecture that may relate to an increase in fatigue. These
changes will be measured by actigraphy, PSG, and patient self-reporting techniques (e.g.,
sleep diaries, questionnaires).
The primary objective is to:
- examine the role of delta sleep in the development of chemotherapy-induced fatigue in
cancer patients
Secondary objectives are to:
- characterize the involvement of other elements of sleep architecture [e.g., rapid eye
movement (REM) sleep] and changes in sleep continuity relating to the development of
chemotherapy-induced fatigue in cancer patients
- examine the role of sleep architecture in the persistence of chemotherapy-induced
fatigue
- examine (in post hoc analyses) the relationship of various physical symptoms and
patient variables that may be related to fatigue (e.g., pain, hot flashes, anxiety,
hemoglobin, menopausal status, sleep continuity, and QOL) and to each other, both
during and following chemotherapy.
Answers to these questions will provide information that will be helpful in developing
potential targets for interventions to reduce fatigue.
;
Time Perspective: Prospective
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05346796 -
Survivorship Plan HEalth REcord (SPHERE) Implementation Trial
|
N/A | |
Recruiting |
NCT05094804 -
A Study of OR2805, a Monoclonal Antibody Targeting CD163, Alone and in Combination With Anticancer Agents
|
Phase 1/Phase 2 | |
Completed |
NCT04867850 -
Effect of Behavioral Nudges on Serious Illness Conversation Documentation
|
N/A | |
Enrolling by invitation |
NCT04086251 -
Remote Electronic Patient Monitoring in Oncology Patients
|
N/A | |
Completed |
NCT01285037 -
A Study of LY2801653 in Advanced Cancer
|
Phase 1 | |
Completed |
NCT00680992 -
Study of Denosumab in Subjects With Giant Cell Tumor of Bone
|
Phase 2 | |
Completed |
NCT00062842 -
Study of Irinotecan on a Weekly Schedule in Children
|
Phase 1 | |
Active, not recruiting |
NCT04548063 -
Consent Forms in Cancer Research: Examining the Effect of Length on Readability
|
N/A | |
Completed |
NCT04337203 -
Shared Healthcare Actions and Reflections Electronic Systems in Survivorship
|
N/A | |
Recruiting |
NCT04349293 -
Ex-vivo Evaluation of the Reactivity of the Immune Infiltrate of Cancers to Treatments With Monoclonal Antibodies Targeting the Immunomodulatory Pathways
|
N/A | |
Terminated |
NCT02866851 -
Feasibility Study of Monitoring by Web-application on Cytopenia Related to Chemotherapy
|
N/A | |
Active, not recruiting |
NCT05304988 -
Development and Validation of the EFT for Adolescents With Cancer
|
||
Completed |
NCT04448041 -
CRANE Feasibility Study: Nutritional Intervention for Patients Undergoing Cancer Surgery in Low- and Middle-Income Countries
|
||
Completed |
NCT00340522 -
Childhood Cancer and Plexiform Neurofibroma Tissue Microarray for Molecular Target Screening and Clinical Drug Development
|
||
Recruiting |
NCT04843891 -
Evaluation of PET Probe [64]Cu-Macrin in Cardiovascular Disease, Cancer and Sarcoidosis.
|
Phase 1 | |
Active, not recruiting |
NCT03844048 -
An Extension Study of Venetoclax for Subjects Who Have Completed a Prior Venetoclax Clinical Trial
|
Phase 3 | |
Completed |
NCT03167372 -
Pilot Comparison of N-of-1 Trials of Light Therapy
|
N/A | |
Completed |
NCT03109041 -
Initial Feasibility Study to Treat Resectable Pancreatic Cancer With a Planar LDR Source
|
Phase 1 | |
Terminated |
NCT01441115 -
ECI301 and Radiation for Advanced or Metastatic Cancer
|
Phase 1 | |
Recruiting |
NCT06206785 -
Resting Energy Expenditure in Palliative Cancer Patients
|